Frontiers in Immunology (Dec 2020)
Editorial: Modulation of Human Immune Parameters by Anticancer Therapies
- Ulrich Sack,
- Attila Tarnok,
- Attila Tarnok,
- Attila Tarnok,
- Frank Preijers,
- Ulrike Köhl,
- Ulrike Köhl,
- Ulrike Köhl,
- Il-Kang Na,
- Il-Kang Na,
- Il-Kang Na,
- Il-Kang Na
Affiliations
- Ulrich Sack
- Medical Faculty, Institute of Clinical Immunology, Leipzig University, Leipzig, Germany
- Attila Tarnok
- Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany
- Attila Tarnok
- Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany
- Attila Tarnok
- Department Precision Instruments, Tsinghua University, Beijing, China
- Frank Preijers
- Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
- Ulrike Köhl
- Medical Faculty, Institute of Clinical Immunology, Leipzig University, Leipzig, Germany
- Ulrike Köhl
- Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany
- Ulrike Köhl
- Institute for Cellular Therapeutics, Hannover Medical School, Hannover, Germany
- Il-Kang Na
- Department of Hematology and Oncology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- Il-Kang Na
- Experimental and Clinical Research Center (ECRC), Berlin, Germany
- Il-Kang Na
- Berlin Institute of Health (BIH), Berlin, Germany
- Il-Kang Na
- 0German Cancer Consortium (DKTK), partner site Berlin, Heidelberg, Germany
- DOI
- https://doi.org/10.3389/fimmu.2020.621556
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
- immunoncology
- flow cytometry
- checkpoint inhibition/blockade
- immune modulation
- tumor-immune cell interaction